Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled

• Description:

  Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled_x000D_ Catalog number: B2019512_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: 4516_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: FITC-LC-LSELDDRADALQAGASQFESSAAKLKRKYWWKNLK-NH2_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Elliott M, Maignel J, Liu SM, Favre-Guilmard C, Mir I, Farrow P, Hornby F, Marlin S, Palan S, Beard M, Krupp J. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems PLoS One. 2017 Oct 5;12(10):e0185628._x000D_ 2: Yi KH, Lee JH, Lee K, Hu HW, Lee HJ, Kim HJ. Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Platysma Muscle for Treating Platysmal Band and Jawline Lifting: A Review Toxins (Basel). 2022 Dec 10;14(12):868._x000D_ 3: Yi KH, Lee JH, Hu HW, Kim HJ. Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines Toxins (Basel). 2022 Apr 10;14(4):268._x000D_ 4: Yeung W, Richards AL, Novakovic D. Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia Toxins (Basel). 2022 Dec 1;14(12):844._x000D_ 5: Dong M, Masuyer G, Stenmark P. Botulinum and Tetanus Neurotoxins Annu Rev Biochem. 2019 Jun 20;88:811-837._x000D_ 6: Lúquez C, Halpin JL, Dykes J. Unintended consequences: Renaming botulinum neurotoxin-producing species of clostridium and related species Toxicon. 2023 Mar 1;224:107036._x000D_ 7: Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Childhood Opisthotonus Toxins (Basel). 2021 Feb 12;13(2):137._x000D_ 8: Sugiyama H. Clostridium botulinum neurotoxin Microbiol Rev. 1980 Sep;44(3):419-48._x000D_ 9: Jost WH, Berberovic E. Therapy with botulinum neurotoxin for Parkinson's disease J Neural Transm (Vienna). 2024 Nov;131(11):1321-1328._x000D_ 10: Jost WH. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal Toxins (Basel). 2021 Jan 25;13(2):87. _x000D_ _x000D_ Products Related to Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled can be found at Peptides

• Short Description:

  Catalog Number: B2019512 (1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5